RESULTS
Initial treatment stabilized respiratory function in most patients and improved walking performance. The median duration of treatment withdrawal was 10.6 months (range 3.1-59.3 months). Afterwards, FVC declined in most, and the 6-MWT declined in all patients. Two patients needed additional non-invasive ventilatory support. Twelve months after ERT retreatment, respiratory and walking capacity improved in most patients. Aside from one patient each, none of the patients reached the levels of respiratory function and walking capacity at the time of ERT withdrawal.
CONCLUSIONS
Long-term interruption (>3 months) of ERT in Pompe disease causes a decline in clinical function. Resuming treatment only partially recovers respiratory function and walking capacity. These should be taken into account when ERT is interrupted for whatever reason.
